General Information of Drug (ID: DMPG277)

Drug Name
KB103
Indication
Disease Entry ICD 11 Status REF
Dystrophic epidermolysis bullosa EC32 Phase 2 [1]
Cross-matching ID
TTD ID
D0B1GE

References

1 ClinicalTrials.gov (NCT03536143) Topical Beremagene Geperpavec (KB103) Gene Therapy to Restore Functional Collagen VII for the Treatment of Dystrophic Epidermolysis Bullosa (GEM-1). U.S. National Institutes of Health.